Clinical Trial Update: The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

View source ↗

Summary

This clinical trial update describes ongoing recruitment for a study assessing urinary tumor DNA/RNA–based liquid biopsy during a second transurethral resection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Bladder Cancer, Liquid Biopsy | Status: RECRUITING